Jeffrey A. Durocher
Jeffrey A. Durocher publishes mostly in Hematology, Oncology and Genetics, on topics such as Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research and Chronic Myeloid Leukemia Treatments.
- World rank
- #2,150,643 of 7,710,434 ranked researchers
- Rank in United States
- #647,168 of 1,627,098
- Works
- 21
- Citations
- 1.7k
- Citations per work
- 80.0
What does Jeffrey A. Durocher research?
Jeffrey A. Durocher's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1256.3%
- Medicine1256.3%
- Everything else522.9%
- Life Sciences420.8%
- 1Hematology21% of their works
- 2Oncology17% of their works
- 3Genetics12% of their works
- 4Molecular Biology10% of their works
- 5Cancer Research10% of their works
- 6Pulmonary and Respiratory Medicine6% of their works
Research topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Cancer Genomics and Diagnostics
- Cytokine Signaling Pathways and Interactions
- Colorectal Cancer Treatments and Studies
- Genetic factors in colorectal cancer
- bioluminescence and chemiluminescence research
Which keywords describe Jeffrey A. Durocher's research?
The keywords of their largest research topics: Acute Myeloid Leukemia, AML, BCR-ABL, Imatinib, JAK2 Mutation, Myelofibrosis, Cancer Genomics and IL-6.
- Reporter Genes
- Molecular Characterization
- KRAS Mutations
- STAT3
- IL-6
- Myelofibrosis
- Imatinib
- Acute Myeloid Leukemia
- AML
- BCR-ABL
- JAK2 Mutation
- Cancer Genomics
- Mutational Signatures
- Cetuximab
- Microsatellite Instability
- Bioluminescence
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- AML51 topic
- Acute Myeloid Leukemia51 topic
- BCR-ABL51 topic
- Imatinib51 topic
- JAK2 Mutation51 topic
- Myelofibrosis51 topic
- Cancer Genomics41 topic
- IL-641 topic
- Mutational Signatures41 topic
- STAT341 topic
- Cetuximab31 topic
- KRAS Mutations31 topic
- Microsatellite Instability31 topic
- Molecular Characterization31 topic
- Bioluminescence21 topic
- Reporter Genes21 topic
Where does Jeffrey A. Durocher work?
Jeffrey A. Durocher's main affiliation in the publication record is Transgenomic (United States), United States.
How many publications and citations does Jeffrey A. Durocher have?
OpenAlex counts 21 works and 1,679 citations for Jeffrey A. Durocher, an h-index of 7, ranking #2,150,643 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jeffrey A. Durocher. Posts are plain text and can be reported.